drugset / Trial / NCT01477736

A Comparison Study of Oxybutynin and Botulinum Toxin for Neurogenic Detrusor Overactivity

NCT01477736

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the effects of oral oxybutynin and intradetrusor injections of botulinum toxin type A on urodynamic parameters and quality of life in patients with neurogenic detrusor overactivity following spinal cord injury.

Timeline

Start
2009-01
Primary completion
2010-11
Completion
2010-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator Botulinum toxin type A Protein / enzyme biologic 300 iu Other
Comparator Oxybutynin Small molecule 5 mg Oral

Indications